Nanoparticle Delivery

Nanoparticles enable the delivery of substances, including nucleic acids and chemotherapeutic drugs, to a targeted region while sparing healthy tissues, thus overcoming adverse systemic effects of gene therapy or drug delivery. Here is the latest research on nanoparticle delivery.

September 3, 2020
Open Access

Multi-functionalised graphene nanoflakes as tumour-targeting theranostic drug-delivery vehicles

Chemical Science
Jennifer LambJason P Holland
September 18, 2020
Open Access

Synthesis and characterization of magnetic nanoparticles coated with polystyrene sulfonic acid for biomedical applications

Science and Technology of Advanced Materials
Bo-Wei ChenDa-Jeng Yao
September 5, 2020

Mannose Conjugated Starch Nanoparticles for Preferential Targeting of Liver Cancer

Current Drug Delivery
Akhlesh Kumar JainSuresh Thareja
September 18, 2020
Open Access

The Formulation of Methylene Blue Encapsulated, Tc-99m Labeled Multifunctional Liposomes for Sentinel Lymph Node Imaging and Therapy

Turkish Journal of Pharmaceutical Sciences
Mine Sİlİndİr GÜnay
September 11, 2020

Engineering Strategies for Lymph Node Targeted Immune Activation

Accounts of Chemical Research
Yong ChenBruno G De Geest
September 13, 2020
Review

In vitro - in vivo correlation of intranasal drug deposition

Advanced Drug Delivery Reviews
S Le GuellecL Vecellio
September 3, 2020

Preparation and antitumor evaluation of quercetin nanosuspensions with synergistic efficacy and regulating immunity

International Journal of Pharmaceutics
Yonghui QiaoXiaohui Pu
September 18, 2020

An injectable, self-healing hydrogel system from oxidized pectin/chitosan/γ-Fe2 O3

International Journal of Biological Macromolecules
De-Qiang LiJun Li
September 10, 2020
Review
Open Access

Multifunctional Gold Nanoparticles: A Novel Nanomaterial for Various Medical Applications and Biological Activities

Frontiers in Bioengineering and Biotechnology
Xiaopei HuHang Zhao
September 13, 2020
Review

Doxorubicin-Loaded Physalis Mottle Virus Particles as a pH-Responsive Prodrug for Cancer Therapy

Biotechnology Journal
He Hu, Nicole F Steinmetz
September 17, 2020

Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis

Acta Biomaterialia
Muhammad NaeemJin-Wook Yoo

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Adult Kidney Organoids at Single Cell Resolution

Single-cell RNA sequencing of the adult human kidney transcriptome can provide molecular information about cell-specific responses to environmental variables and disease states. This information can provide a dataset to benchmark human kidney organoids. Discover the latest research on adult kidney organoids at single cell resolution here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

© 2020 Meta ULC. All rights reserved
/feed-previews/nanoparticle-delivery/1ed6ee9d-86aa-4182-91bf-1c0b5abdb9e2